Amneal Pharmaceuticals LLC et al v. Alembic Pharmaceuticals Ltd. et al
| Amneal Pharmaceuticals LLC and Impax Laboratories, LLC |
| Alembic Pharmaceuticals Ltd. and Alembic Pharmaceuticals, Inc. |
| 1:2026cv00798 |
| July 2, 2026 |
| U.S. District Court for the District of Delaware |
| Jennifer L Hall |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 1 Patent Infringement |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on July 9, 2026. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 11 WAIVER OF SERVICE returned executed by Amneal Pharmaceuticals LLC, Impax Laboratories, LLC: For Alembic Pharmaceuticals Ltd. waiver sent on 7/8/2026, answer due 9/8/2026. (Levine, James Harry) |
| Filing 10 WAIVER OF SERVICE returned executed by Impax Laboratories, LLC, Amneal Pharmaceuticals LLC: For Alembic Pharmaceuticals, Inc. waiver sent on 7/8/2026, answer due 9/8/2026. (Levine, James Harry) |
| Filing 9 Pro Hac Vice Fee - Credit Card Payment received for Andrew P. Zappia, Bryan C. Smith, Alan B. Clement, and L. Andrew Tseng. ( re #8 MOTION for Pro Hac Vice Appearance of Attorney Andrew P. Zappia, Bryan C. Smith, Alan B. Clement and L. Andrew Tseng )( Payment of $ 200, receipt number ADEDC-5012173).(Levine, James Harry) |
| Filing 8 MOTION for Pro Hac Vice Appearance of Attorney Andrew P. Zappia, Bryan C. Smith, Alan B. Clement and L. Andrew Tseng - filed by Amneal Pharmaceuticals LLC, Impax Laboratories, LLC. (Levine, James Harry) |
SO ORDERED, re #8 Motion for Pro Hac Vice Appearance of Attorney Andrew P. Zappia, Bryan C. Smith, Alan B. Clement and L. Andrew Tseng filed by Impax Laboratories, LLC, Amneal Pharmaceuticals LLC. Ordered by Judge Jennifer L. Hall on 7/9/2026. (ceg)
|
| Case Assigned to Judge Jennifer L. Hall. Please include the initials of the Judge (JLH) after the case number on all documents filed. (alb) |
| Filing 7 Summons Issued as to Alembic Pharmaceuticals Ltd. on 7/6/2026; Alembic Pharmaceuticals, Inc. on 7/6/2026. (Attachments: #1 Summons Issued)(mpb) |
| CORRECTING ENTRY: The Docket text of D.I. #6 has been modified to reflect the corrected identification of the Corporate Parent and Other Affiliate for Impax Laboratories, LLC. (mpb) |
| Filing 6 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals LLC and Other Affiliate Amneal Pharmaceuticals, Inc. for Impax Laboratories, LLC - filed by Impax Laboratories, LLC. (mpb) Modified on 7/6/2026 (mpb). |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Amneal Pharmaceuticals, Inc. for Amneal Pharmaceuticals LLC - filed by Amneal Pharmaceuticals LLC. (mpb) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) US 10,098,845; US 10,292,935; US 10,688,058; US 10,973,769 ; US 10,987,313; US 11,357,733 ; US 11,622,941; US 11,666,538; US 12,064,521; US 12,178,918; US 12,403,099; US 12,491,164; US 11,986,449; US 12,109,185; US 12,194,150; US 12,201,596; US 12,303,482; US 12,370,163; US 12,447,139; US 12,453,710; US 12,458,616; US 12,128,141; US 12,178,919; US 12,274,793; US 12,303,605; US 12,263,148; US 12,295,931; US 12,303,481; US 12,263,149. (mpb) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: 5/26/2026. Date of Expiration of Patent(s): 10/7/2034 for US 10,098,845, US 10,292,935, US 10,688,058, US 10,973,769, US 10,987,313, US 11,357,733, US 11,622,941, US 11,666,538, US 12,064,521, US 12,178,918, US 12,403,099, US 12,491,164, US 12,128,141, US 12,178,919, US 12,274,793, US 12,303,605; 12/21/2041 for US 11,986,449, US 12,109,185; US 12,194,150, US 12,201,596, US 12,303,482, US 12,370,163, US 12,447,139, US 12,453,710, US 12,458,616, US 12,263,148, US 12,295,931, US 12,303,481, and US 12,263,149.Thirty Month Stay Deadline: 11/26/2028. (mpb) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (mpb) |
| Filing 1 COMPLAINT for Patent Infringement against Alembic Pharmaceuticals Ltd., Alembic Pharmaceuticals, Inc. (Filing fee $ 405, receipt number ADEDC-5007400) - filed by Impax Laboratories, LLC, Amneal Pharmaceuticals LLC. (Attachments: #1 Exhibit 1, #2 Exhibit 2, #3 Exhibit 3, #4 Exhibit 4, #5 Exhibit 5, #6 Exhibit 6, #7 Exhibit 7, #8 Exhibit 8, #9 Exhibit 9, #10 Exhibit 10, #11 Exhibit 11, #12 Exhibit 12, #13 Exhibit 13, #14 Exhibit 14, #15 Exhibit 15, #16 Exhibit 16, #17 Exhibit 17, #18 Exhibit 18, #19 Exhibit 19, #20 Exhibit 20, #21 Exhibit 21, #22 Exhibit 22, #23 Exhibit 23, #24 Exhibit 24, #25 Exhibit 25, #26 Exhibit 26, #27 Exhibit 27, #28 Exhibit 28, #29 Exhibit 29, #30 Civil Cover Sheet)(mpb) |
Access additional case information on PACER
Use the links below to access additional information about this case on the U.S. Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
